Elucidating the precise pharmacological system of action (MOA) of naturally developing compounds is often hard. Although Tarselli et al. (sixty) formulated the primary de novo synthetic pathway to conolidine and showcased this naturally developing compound successfully suppresses responses to each chemically induced and inflammation-derived pain, t